Order results by:
| Issue | Title | |
| Vol 17, No 4 (2025) | Hyperhomocysteinemia and endothelial dysfunction in multiple sclerosis | Abstract similar documents |
| E. A. Dubchenko, A. N. Boyko, A. V. Ivanov, M. A. Popov, R. A. Maslennikov, M. P. Kruglova, E. V. Silina, E. I. Gusev, A. A. Kubatiev | ||
| "... (EDSS disability level) and increased Hcy levels. A statistically significant increase in ICAM-1 levels ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... Status Scale (EDSS) and the Multiple Sclerosis Severity Score (MSSS). All patients were examined ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... risk of a>0.75 point disability increase in the Expanded Disability Status Scale (EDSS) score ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis | Abstract similar documents |
| I. A. Koltsov, M. Yu. Martynov, A. N. Yasamanova, I. A. Shchukin, M. S. Fidler, A. N. Boyko | ||
| "... Endothelial dysfunction is a universal pathological mechanism underlying or contributing ..." | ||
| Vol 4, No 2 (2012) | Clinical characteristics of multiple sclerosis in the Tomsk region | Abstract similar documents |
| V M Alifirova, M A Titova | ||
| "... прогрессирования болезни. Более благоприятное течение РС наблюдалось у женщин, что проявлялось меньшей ..." | ||
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... эффективность по сравнению с плацебо в замедлении прогрессирования инвалидизации у пациентов с ВПРС в ..." | ||
| Vol 11, No 1 (2019) | The mechanisms for activation of a vascular platelet component of hemostasis in the stroke recovery period and the ways of their correction | Abstract similar documents |
| E. A. Tyutyumova, E. Yu. Solovyeva, A. N. Karneev, E. D. Dzhutova | ||
| "... the concentrations of the inflammatory marker myeloperoxidase and the endothelial dysfunction (ED) markers sICAM-1 ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... специфичностью предсказать и оценить темп прогрессирования заболевания, что существенно помогло бы в определении ..." | ||
| Vol 10, No 1 (2018) | Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases | Abstract similar documents |
| O. N. Voskresenskaya, N. B. Zakharova, Yu. S. Tarasova, N. E. Tereshkina, V. A. Perepelov, E. M. Perepelova | ||
| "... , and the plasma and serum levels of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein ..." | ||
| Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
| A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
| "... was evaluated using the expanded disability status scale (EDSS); pedographic examination was made applying ..." | ||
| Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
| N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
| "... стадии прогрессирования, а также предложения, способствующие улучшению текущего состояния проблемы ВПРС ..." | ||
| Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
| Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
| "... Hospital One. The Expanded Disability Status Scale (EDSS) was used to evaluate the severity of the disease ..." | ||
| Vol 14, No 1 (2022) | Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study | Abstract similar documents |
| O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva | ||
| "... between the level of peripheral markers of endothelial inflammation and depression severity in patients ..." | ||
| Vol 7, No 4 (2015) | Migraine and hypertension | Abstract similar documents |
| G. R. Tabeeva, A. V. Muranova, E. N. Kostrygina, A. V. Sergeev | ||
| "... between hypertension and endothelial dysfunction. Identification of groups of patients having migraine ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... scale (VAS) for pain, PASAT test, EDSS. We performed an MRI scan, and identified significant stressful ..." | ||
| Vol 14, No 2 (2022) | New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. | Abstract similar documents |
| A. K. Minochkin, V. Yu. Lobzin, N. N. Suchentseva, O. S. Popov, S. V. Apalko, S. G. Sherbak | ||
| "... is a marker of endothelial dysfunction, may be an indicator of the severity of the vascular neurodegenerative ..." | ||
| Vol 15, No 6 (2023) | Association of cognitive impairment and arterial hypertension | Abstract similar documents |
| O. Yu. Isaykina, K. A. Vekhova, G. S. Drobotov, R. A. Takhirov, M. A. Isaykina, V. M. Gorbunov | ||
| "... on the effects of endothelial dysfunction and increased arterial stiffness on CF. The small number of papers ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... .47 years), mean Expanded Disability Status Scale (EDSS) score – 2.91±1.67. 86% of patients had relapsing ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan | Abstract similar documents |
| A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova | ||
| "... and cerebellar ataxia. Students also had a faster MS progression (0.4 [0.2; 0.6] EDSS scores per year, p=0 ..." | ||
| Vol 8, No 4 (2016) | IMPACT OF ANTICOAGULANT THERAPY ON THE INDICATORS OF ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CARDIOEMBOLIC STROKE | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin, I. E. Poverennova, N. P. Romanchuk | ||
| "... stiffness and endothelial dysfunction (ED) in patients with atrial fibrillation (AF) after cardioembolic ..." | ||
| Vol 16, No 2 (2024) | Laboratory indicators of hemostasis, lipid metabolism and endothelial dysfunction in men aged 18–50 years with different subtypes of ischemic stroke | Abstract similar documents |
| N. A. Pizov, N. S. Baranova | ||
| "... Objective: to evaluate laboratory parameters of hemostasis, lipid metabolism and endothelial ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... -year risk of reaching 6.5 Expanded Disability Status Scale (EDSS) scores. Patients and methods ..." | ||
| Vol 2, No 2 (2010) | Cervicogenic headache: the specific features of complex therapy with Amelotex and CompligamV | Abstract similar documents |
| M. L. Pospelova | ||
| "... the sensory-discriminative and affective-motivational pain components. The therapy did not worsen endothelial ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... Expanded Disability Status Scale (EDSS) score was 4.0; the most severe course of the disease was observed ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... functional system (PFS) impairment according to EDSS, patients were divided into 2 groups; group 1 — 17 ..." | ||
| Vol 5, No 1 (2013) | Clinical value of the major types of reactions of the body’s stress-regulating systems in ischemic stroke | Abstract similar documents |
| Aleksandr Mikhailovich Dolgov, A Yu Ryabchenko | ||
| Vol 16 (2024): (Suppl. 2) | High-dose immunosuppressive therapy followed by haematopoietic stem cell transplantation as a method for the treatment of refractory forms of neuromyelitis optica spectrum disorder in children | Abstract similar documents |
| N. N. Bronina, O. V. Bykova, G. O. Bronin, A. E. Kessel, G. Z. Seregin, K. I. Kirgizov, A. Yu. Polushin, T. T. Batysheva | ||
| "... ’s neurological deficit progressed to 9.5 points on the Expanded Disability Status Scale (EDSS). After ..." | ||
| Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
| V. V. Kovalchuk | ||
| Vol 10, No 2 (2018) | Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov | ||
| "... and discussion. GS interacts with the receptors CD44, TLR4, and ICAM1 on the surface of chondrocytes, inhibits ..." | ||
| Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
| N. N. Koberskaya, F. A. Roshchin | ||
| "... deficits, in reducing cerebral vasospasm and endothelial dysfunction in viral infections. Memantine therapy ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... age 32.9 years, mean EDSS severity 3.8 points) with MS underwent outpatient continuous active art ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... , cervical and thoracic spine, and chest X-ray, Expanded Disability Status Scale (EDSS) scoring, clinical ..." | ||
| Vol 15 (2023): (Suppl. 1) | Distinctive parameters of gait in patients with multiple sclerosis, depending on the profile of its dysfunction | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| "... in the EDSS range up to 5.5 points – the step width, the value of which is greater in patients with ataxia ..." | ||
| Vol 17, No 4 (2025) | Cognitive changes in multiple sclerosis and factors of their development: association with taking disease-modifying therapies | Abstract similar documents |
| A. O. Komissarenko, V. V. Grinyuk, A. S. Bakhchivanov, E. V. Yashchuk, E. S. Fatueva, K. Yu. Komissarenko, N. V. Vakhnina, V. V. Zakharov, N. S. Babieva | ||
| "... , prolonged course of the disease, high degree of disability according to EDSS. Modifiable risk factors for CI ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... additional therapy with micellar curcumin for 6 months (IFN-C group). Clinical (relapses, MRI activity, EDSS ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Scale (EDSS), complete blood count, monitoring of blood lymphocytes level and biochemical blood testing ..." | ||
| Vol 16, No 6 (2024) | Vitamins and other nutrients that support nitric oxide homeostasis and counteract the development of endotheliopathy | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, L. A. Mayorova | ||
| "... on vascular endothelial function, NO synthase activity and the prevention of oxidative-nitrosative stress ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... imaging (MRI) (at least 1.5 T) and electroencephalography (EEG), EDSS health assessment, antiepileptic ..." | ||
| Vol 15 (2023): (Suppl. 1) | Features of multiple sclerosis in childhood in the Republic of Tatarstan | Abstract similar documents |
| A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin | ||
| "... condition was assessed using the Expanded Disability Status Scale (EDSS). Results. MS was diagnosed in 99 ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... 15 to 60 years (mean age 39.7±10.91 years). Disability according to the EDSS scale was 2.51±1 ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... of patients who participated in TeleRBT, the level of disability on the EDSS scale did not change; walking ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... year of treatment and by 97.4% after the second year of treatment. The mean EDSS score was 3.2±2 ..." | ||
| Vol 17, No 4 (2025) | Experience with the use of sampeginterferon beta-1a in real clinical practice in the Moscow region | Abstract similar documents |
| A. N. Peshkin, V. Yu. Lyzhdvoy, S. V. Kotov, M. V. Sutormin | ||
| "... in neurological deficit on the EDSS scale throughout the observation period. All recorded adverse reactions were ..." | ||
| Vol 13, No 1 (2021) | New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis | Abstract similar documents |
| D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva | ||
| "... прогрессирование. Данная статья отражает позицию совета ведущих экспертов в области РС в отношении раннего ..." | ||
| Vol 1, No 2 (2009) | METABOLIC CORRECTION OF NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS | Abstract similar documents |
| S. A. Rumyantseva, V. A. Stupin, E. V. Silina, V. V. Mikhal'skiy, A. I. Perevedentsev, D. D. Ryzhova | ||
| "... Представлены метаболические и сосудистые механизмы возникновения и прогрессирования неврологических ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... and 5 men; age – 41.6±7.7 years; EDSS – 4.0 [3.5; 5.0] points, duration of MS – 8.0 [3.0; 21.0] years ..." | ||
| Vol 16 (2024): (Suppl. 2) | Pain in patients with neuromyelitis optica spectrum disorders | Abstract similar documents |
| E. S. Novikova, A. S. Kotov, S. V. Kotov | ||
| "... and severity of the pain syndrome: Expanded Disability Status Scale (EDSS), Diagnostic Neuropathic Pain ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... on the EDSS scale, the severity of chronic fatigue on the MFIS scale, the quality of life on the SF-36 scale ..." | ||
| Vol 13, No 4 (2021) | Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| S. V. Kotov, E. S. Novikova, A. S. Kotov | ||
| "... by the average annualized relapse rate, the median changes of the Expanded Disability Status Scale (EDSS ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... of exacerbations and an increase in Expanded Disability Status Scale (EDSS) scores prior to being prescribed ..." | ||
| Vol 17, No 4 (2025) | The role of central vein sign in differential diagnostics of neuromyelitis optica spectrum disorders and multiple sclerosis | Abstract similar documents |
| S. V. Kotov, E. S. Novikova, G. T. Tonya, A. S. Kotov | ||
| "... . The Expanded Disability Status Scale (EDSS) was used to assess neurological status. In addition to the routine ..." | ||
| Vol 13, No 2 (2021) | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions | Abstract similar documents |
| V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov | ||
| "... , endothelial dysfunction, coagulopathy, thrombus formation, systemic inflammatory reaction, the consequences ..." | ||
| Vol 11, No 3 (2019) | Advances in neurometabolic therapy | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina | ||
| "... species, and normalizes the endothelial function of small vessels. The drug has not been shown ..." | ||
| Vol 11, No 2 (2019) | Vascular factors in the genesis of dementia and the optimization of patient management | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... , профилактику инсульта и прогрессирования хронической цереброваскулярной патологии и, следовательно, на ..." | ||
| Vol 11, No 4 (2019) | Poststroke cognitive impairment | Abstract similar documents |
| V. A. Parfenov | ||
| "... профилактика прогрессирования КН основаны на профилактике инсульта, нелекарственных и лекарственных методах ..." | ||
| Vol 13, No 3 (2021) | Management tactics in patients with chronic cerebral ischemia during COVID-19 pandemic | Abstract PDF (Eng) similar documents |
| A. A. Kulesh | ||
| "... due to vascular remodeling, increased arterial stiffness, endothelial dysfunction, impaired ..." | ||
| Vol 15, No 2 (2023) | Depression in patients with cerebral microangiopathy | Abstract similar documents |
| A. N. Bogolepova | ||
| "... and endothelial dysfunction, metabolic risk factors, – are risk factors for the development of depression ..." | ||
| Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
| I. V. Milyukhina | ||
| "... скорость прогрессирования заболевания и повышающее риск развития двигательных осложнений и деменции. В ..." | ||
| Vol 11, No 2 (2019) | Diabetic polyneuropathy: a current algorithm for patient management | Abstract similar documents |
| L. T. Akhmedzhanova, A. N. Barinov, O. A. Solokha, I. A. Strokov, O. B. Doronina, K. S. Doronina, A. S. Rozhdestvensky | ||
| "... сахарного диабета (СД) и может развиваться уже на стадии предиабета. По мере прогрессирования и в отсутствие ..." | ||
| Vol 9, No 2 (2017) | Chronic cerebral ischemia, neuroplasticity, possibilities of therapy | Abstract similar documents |
| E. I. Chukanova, A. S. Chukanova | ||
| "... проявлений, прогрессирование и риск возникновения обострений у пациентов с хронической ишемией мозга. ..." | ||
| Vol 4, No 3 (2012) | Transient ischemic attack is a multidisciplinary problem | Abstract similar documents |
| Valentina Vladimirovna Gudkova, T V Shanina, E A Petrova, L V Stakhovskaya | ||
| "... ТИА отмечаются высокий риск развития ишемического инсульта и опасность формирования и прогрессирования ..." | ||
| Vol 15, No 3 (2023) | Inflammatory biomarkers and growth factors in patients with chronic cerebrovascular disease after coronavirus infection | Abstract similar documents |
| E. B. Kuznetsova, O. N. Voskresenskaya, N. B. Zakharova, N. S. Kuznetsov | ||
| "... ); chemokines – monocytic chemoattractant protein 1 (MCP-1), IL8; growth factors – vascular endothelial growth ..." | ||
| Vol 7, No 3 (2015) | Cognitive impairments in common and rare somatic diseases | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... иммунная патология, секвестрация молекул, гибель клетки. По мере прогрессирования цереброваскулярной ..." | ||
| Vol 13, No 5 (2021) | Treatment of cognitive impairment in arterial hypertension | Abstract similar documents |
| Yu. A. Starchina, K. S. Sleptcova | ||
| "... замедлении прогрессирования КН посредством контроля артериального давления. В обзоре обсуждается применение ..." | ||
| Vol 10, No 3 (2018) | Benign syringomyelia with the abortive type of the course | Abstract PDF (Eng) similar documents |
| E. G. Mendelevich, Ch. S. Nurullina | ||
| "... заболевания в детском возрасте, отсутствие прогрессирования и/или развития миелопатических симптомов, признаки ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular depression and cognitive dysfunction | Abstract similar documents |
| A. N. Bogolepova | ||
| "... оказывает негативное влияние на течение сердечно-сосудистой патологии, способствуя ее прогрессированию ..." | ||
| Vol 8, No 3 (2016) | Amyotrophic lateral sclerosis with extension of the central canal of the spinal cord according to magnetic resonance imaging data | Abstract similar documents |
| E. G. Mendelevich, G. R. Mukhamedzhanova, E. I. Bogdanov | ||
| "... признаков, таких как начало в молодом возрасте, медленное прогрессирование с длительным вовлечением ..." | ||
| Vol 9, No 2 (2017) | Cognitive impairment without dementia: A current view of the problem | Abstract similar documents |
| Yu. A. Starchina | ||
| "... факторов риска позволяет сдерживать прогрессирование КН. Обсуждается применение EGB761® у пациентов с КН. ..." | ||
| Vol 1, No 3-4 (2009) | COMPLEX THERAPY FOR HYPERTENSIVE AND MIXED ENCEPHALOPATHY | Abstract similar documents |
| S. A. Rumyantseva | ||
| "... Одной из главных причин возникновения и прогрессирования разных видов сосудистой патологии является ..." | ||
| Vol 5, No 4 (2013) | Cognitive impairments in epilepsy | Abstract similar documents |
| Aleksandr Anatolyevich Kostylev, N V Pizova, N A Pizov | ||
| "... позволяют выявлять новые особенности течения и прогрессирования нарушений функций высшей нервной ..." | ||
| 1 - 70 of 123 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
